BACKGROUND Premedication is expedient in reducing the psychological trauma from recalling the unpleasant pre-anaesthetic phases; hence, inducing a trouble-free anaesthesia. Aim-This study was done to evaluate commercially available midazolam syrup 0.25 mg/kg as a premedication in children with regard to sedation, anxiolysis and parental separation score. MATERIALS AND METHODS After IRB approval and written informed consent from parents, this study was conducted in 100 children (ASA I and II), aged 1 to 6 years who were scheduled for various elective and emergency surgeries. Patients were randomly divided into two groups (n= 50 each). Group A was control and Group B received midazolam syrup 0.25 mg/kg 45 minutes before surgery. RESULTS The acceptance of drug was very good. All children in Group A (without premedication) were extremely anxious and crying or thrashing, while in Group B 98% patients were calm and sleepy and separated happily from parents after 45 minutes. Midazolam did not impact the overall recovery time in children. None of the patients in either group developed any complication. CONCLUSION A dose of 0.25 mg/kg of commercially available midazolam syrup offers effective sedation and better emotional control facilitating better separation from parents.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.